Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

Two Of Sanofi's Hepatitis B Vaccines Win EU Clearance

May 17, 2006

By Peter O'Donnell

Two Of Sanofi's Hepatitis B Vaccines Win EU Clearance

May 17, 2006

By Peter O'Donnell

European Union Makes Bid To Boost Biotech Start-ups

May 10, 2006

By Peter O'Donnell

European Union Makes Bid To Boost Biotech Start-ups

May 10, 2006

By Peter O'Donnell

Rivalry Resurfaces Among EU Biotechnology Trade Groups

May 3, 2006

By Peter O'Donnell

Rivalry Resurfaces Among EU Biotechnology Trade Groups

May 3, 2006

By Peter O'Donnell

Omnitrope Approved, Becomes First 'Biosimilar' Cleared In EU

April 26, 2006

By Peter O'Donnell

Omnitrope Approved, Becomes First 'Biosimilar' Cleared In EU

April 26, 2006

By Peter O'Donnell

Biotech Firms Want More Incentives For EU Orphans

April 12, 2006

By Peter O'Donnell

Biotech Firms Want More Incentives For EU Orphans

April 12, 2006

By Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...